UBS Group Cuts Ingredion (NYSE:INGR) Price Target to $122.00

Key Points

• UBS cut its price target on Ingredion from $124 to $122 and maintained a "neutral" rating, while the analyst consensus remains a Hold with an average target of $126.14.
• Earnings miss: Ingredion reported Q EPS of $2.53 versus $2.59 expected and slightly weaker revenue, and set FY2026 guidance of $11.00–$11.80 EPS (consensus ~11.14).
• Insider selling has been notable — CEO James P. Zallie sold 9,958 shares and insiders disposed of 48,686 shares (~$5.78M) over the last 90 days, though insiders still own 2.30% of the company.

Ingredion (NYSE:INGR - Get Free Report) had its target price dropped by equities research analysts at UBS Group from $124.00 to $122.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a "neutral" rating on the stock. UBS Group's price objective would indicate a potential upside of 6.23% from the company's previous close.

Several other equities research analysts have also weighed in on the company. Stephens reissued an "equal weight" rating and issued a $120.00 price objective on shares of Ingredion in a report on Wednesday, February 4th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Ingredion in a report on Friday, March 27th. Barclays increased their target price on shares of Ingredion from $124.00 to $128.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 4th. Benchmark initiated coverage on shares of Ingredion in a research report on Tuesday, March 17th. They issued a "buy" rating and a $130.00 price target on the stock. Finally, Wall Street Zen cut shares of Ingredion from a "buy" rating to a "hold" rating in a research note on Saturday, January 31st. Two research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, Ingredion currently has a consensus rating of "Hold" and an average target price of $126.14.

Ingredion Stock Performance

Shares of NYSE:INGR traded up $1.28 during mid-day trading on Thursday, reaching $114.84. The company had a trading volume of 386,683 shares, compared to its average volume of 658,569. Ingredion has a one year low of $102.31 and a one year high of $141.78. The company has a current ratio of 2.66, a quick ratio of 1.73 and a debt-to-equity ratio of 0.41. The company's 50-day moving average price is $114.89 and its 200-day moving average price is $114.08. The firm has a market cap of $7.23 billion, a price-to-earnings ratio of 10.29, a PEG ratio of 0.89 and a beta of 0.70.

Ingredion (NYSE:INGR - Get Free Report) last released its earnings results on Tuesday, February 3rd. The company reported $2.53 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.59 by ($0.06). The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.78 billion. Ingredion had a return on equity of 17.32% and a net margin of 10.10%.The business's quarterly revenue was down 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $2.63 earnings per share. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. As a group, equities research analysts anticipate that Ingredion will post 11.14 EPS for the current fiscal year.

Insider Activity

In other news, CEO James P. Zallie sold 9,958 shares of the company's stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $116.55, for a total transaction of $1,160,604.90. Following the sale, the chief executive officer directly owned 33,011 shares in the company, valued at $3,847,432.05. This represents a 23.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Davida Marie Gable sold 375 shares of the stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $112.44, for a total transaction of $42,165.00. Following the completion of the sale, the vice president directly owned 7,110 shares in the company, valued at approximately $799,448.40. The trade was a 5.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 48,686 shares of company stock worth $5,784,010 over the last ninety days. Company insiders own 2.30% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of INGR. Massachusetts Financial Services Co. MA grew its stake in Ingredion by 2.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,369,448 shares of the company's stock worth $167,223,000 after buying an additional 29,433 shares in the last quarter. Dover Advisors LLC bought a new stake in shares of Ingredion during the 3rd quarter worth $1,710,000. Oxbow Advisors LLC purchased a new position in Ingredion in the third quarter worth $2,784,000. Cooke & Bieler LP grew its position in Ingredion by 16.0% in the third quarter. Cooke & Bieler LP now owns 903,346 shares of the company's stock worth $110,308,000 after acquiring an additional 124,517 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd increased its stake in Ingredion by 479.3% in the third quarter. Y Intercept Hong Kong Ltd now owns 24,434 shares of the company's stock valued at $2,984,000 after acquiring an additional 20,216 shares during the last quarter. 85.27% of the stock is owned by institutional investors.

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company's product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.